Form 4: Director Nelson Boosts CODX Stake with RSU Vesting

Co-Diagnostics Director James B. Nelson acquired 57,499 shares of common stock and restricted stock units through vesting events.

Summary

• James B. Nelson, a Director of Co-Diagnostics, Inc. (CODX), reported changes in his beneficial ownership.
• On November 23, 2025, Nelson acquired 57,499 shares of common stock at a price of $0.00.
• Following this transaction, Nelson directly owns 269,166 shares of common stock.
• He also reported the acquisition of 57,499 Restricted Stock Units (RSUs) at a price of $0.00, which converted into common stock upon vesting.
• The acquired RSUs are part of previously awarded grants from January 17, 2023 (40,000 units), June 12, 2023 (70,000 units), April 26, 2024 (110,000 units), and August 13, 2025 (125,000 units), all granted pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan.
• These RSU awards vest in six equal installments every six months, with the latest vesting event occurring on November 23, 2025.
• After the transaction, Nelson beneficially owns 170,834 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is a routine vesting event, which is expected. The positive aspect is a director increasing their stake, which can be seen as a sign of confidence, but it's not a discretionary open-market purchase.

Positives

• A director increasing their direct ownership in the company through vesting events can signal continued alignment with shareholder interests.
• The vesting of restricted stock units is a standard component of executive compensation, aligning management's long-term incentives with the company's performance.

Future Outlook

This filing does not contain forward-looking statements or guidance, as it is a report of a past transaction.

Industry Context

This Form 4 filing is a routine insider transaction report detailing a director's equity compensation vesting. It does not provide information relevant to broader industry trends or competitive landscape analysis.

Stakeholder Impact

• Shareholders: The transaction increases the director's direct equity ownership, which generally aligns the director's financial interests more closely with those of the shareholders.
• Employees: The existence of the 2015 Long Term Incentive Plan indicates a structured approach to long-term equity compensation for key personnel, including directors.

Next Steps

• Future vesting installments for the remaining restricted stock units will occur every six months from their respective commencement dates, as per the terms of the 2015 Long Term Incentive Plan.

Key Dates

Recommendation

This Form 4 filing reports a routine vesting of restricted stock units for a director, which is an expected event under the company's long-term incentive plan. While it increases the director's beneficial ownership, signaling continued alignment, it does not represent a discretionary open-market purchase or provide new fundamental information to warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Co-Diagnostics, CODX, Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, RSU, Director Compensation, Equity Compensation, Vesting